000 01534 a2200421 4500
005 20250511212259.0
264 0 _c19910827
008 199108s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/BF00685517
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGustafson, D L
245 0 0 _aInhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1991
300 _a228-30 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAcetylcysteine
_xpharmacology
650 0 4 _aAerobiosis
_xdrug effects
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xantagonists & inhibitors
650 0 4 _aAntioxidants
_xpharmacology
650 0 4 _aAzoles
_xpharmacology
650 0 4 _aCell Hypoxia
_xdrug effects
650 0 4 _aCell Line
650 0 4 _aDimethyl Sulfoxide
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aIsoindoles
650 0 4 _aMice
650 0 4 _aMitomycin
650 0 4 _aMitomycins
_xantagonists & inhibitors
650 0 4 _aOrganoselenium Compounds
650 0 4 _aPorfiromycin
_xtoxicity
650 0 4 _aSelenium
_xpharmacology
650 0 4 _aTumor Cells, Cultured
_xdrug effects
700 1 _aPritsos, C A
773 0 _tCancer chemotherapy and pharmacology
_gvol. 28
_gno. 3
_gp. 228-30
856 4 0 _uhttps://doi.org/10.1007/BF00685517
_zAvailable from publisher's website
999 _c1912983
_d1912983